OPC PHARMA Sets Strategic Vision at 2026 Annual General Meeting

OPC PHARMA successfully wrapped up its 2026 Annual General Meeting (AGM) on April 25th at the corporate headquarters. The event served as a pivotal moment for the company to look back on its previous term’s achievements while securing shareholder approval for key 2026 mandates. More importantly, the meeting laid the groundwork for a bold new chapter in OPC PHARMA’s strategic expansion.

Strong Financial Performance: A Catalyst for Sustainable Growth

Despite a challenging market landscape in 2025, OPC PHARMA maintained a remarkable growth trajectory. Consolidated revenue surged to VND 1,124.55 billion, marking a 16% year-on-year increase. This robust performance stands as a testament to the company’s aggressive restructuring efforts, strategic redistribution of sales channels, and optimized operational management over the past year. Beyond the top-line growth, OPC PHARMA remains laser-focused on enhancing profit quality and streamlining costs, solidifying a rock-solid financial foundation for its long-term ambitions.

The 2026 Roadmap: Sustaining Momentum and Scaling Up

At the meeting, shareholders gave a resounding green light to the 2026 business plan, setting ambitious targets of VND 1,250 billion in consolidated revenue and VND 175 billion in consolidated pre-tax profit. These figures underscore OPC PHARMA’s proactive stance and fierce determination to scale its operations and capture a larger market share. Even as the pharmaceutical sector faces intensifying competition, OPC PHARMA remains committed to maintaining a steady, high-performance growth rate.

Dividend Policy: Balancing Shareholder Returns with Strategic Growth

A major highlight of the meeting was the profit distribution plan, which received significant attention from attendees. Shareholders approved a 2025 dividend payout of 25%, consisting of 8% in cash and 17% in shares. Looking ahead to 2026, OPC PHARMA aims to maintain a minimum dividend rate of 12% of charter capital. This robust payout policy not only reflects the company’s strong liquidity but also underscores its steadfast commitment to delivering long-term value and growing alongside its investors.

Governance Excellence: Primed for a New Era of Growth 

The meeting successfully elected five members to the Board of Directors for the 2026–2031 term, including:

• Mr. Trinh Xuan Vuong
• Mr. Hoang Le Son
• Ms. Pham Thi Xuan Huong
• Mr. Le Tri Thong
• Ms. Han Thi Khanh Vinh

A landmark development in this term is the formal adoption of a modernized management model, highlighted by the establishment of the Audit Committee under the Board of Directors. This strategic move is designed to streamline the organizational structure, bolster oversight and risk management capabilities, and align the company with international best practices in corporate governance.

Long-term Strategy: From Tradition to a Comprehensive Healthcare Ecosystem

For the 2026–2031 tenure, OPC PHARMA is set to undergo a fundamental transformation, evolving from a traditional herbal manufacturer into a comprehensive healthcare provider. To fuel this breakthrough, the company will focus on five strategic pillars:

• Scaling Up GACP-WHO Standards: Expanding specialized raw material areas to meet rigorous international GACP-WHO certifications.

• Vertical Integration: Investing in localized extraction centers within cultivation zones to ensure absolute control over the supply chain.

• Innovation-Led Growth: Accelerating R&D initiatives to bring cutting-edge health solutions to market.

• Digital Transformation: Leveraging advanced technology to digitalize and optimize every aspect of management and operations.

• Global Integration: Fostering international partnerships to gain early access to world-class pharmaceutical technologies.

Beyond sharpening our competitive edge, these initiatives are a bold step toward elevating the global standing of Vietnamese herbal medicine. With a rock-solid foundation and the unified strength of our shareholders and employees, OPC PHARMA enters this new era with unwavering confidence and a relentless drive for a historic breakthrough.

  OPC – GREEN BRAND, RISING TO INTEGRATE 🌿

OPC PHARMA